Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2023-07-20
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Paired Non-inferiority Study Comparing Overture Semi-automated Vitrification System ("DaVitri") to Standard Manual Process for Clinical Pregnancy Outcomes
NCT06853418
Automation of the In Vitro Fertilization Laboratory
NCT06581068
Automation of Oocyte and Embryo Vitrification
NCT07197983
Validation of Donor Oocytes Semi-automated Vitrification
NCT06238570
Interest of Automated Oocyte Freezing
NCT03570073
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of the study is to validate the viability of the semi automated vitrification process, to obtain survival rates similar to or superior to manual processes, and also the capacity to provide greater reproducibility in the results.
The semi automatic exchange of vitrification fluids in human oocytes is as efficient as the manual procedure, in terms of survival (85-90%), but with significantly lower variability between technicians and between centers (95% reproducibility), as well as reduced manual processing times.
The initial hypothesis is that semi automated vitrification equals or improves the manual technique, thus introducing a new standardized protocol for clinical use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Manual
Oocytes will be prepared for vitrification using the manual protocol
Manual Vitrification
Oocytes will be prepared for vitrification using the manual protocol
Automated
Oocytes will be prepared for vitrification using Davitri device
Automated Vitrification
Oocytes will be prepared for vitrification using the DaVitri device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Manual Vitrification
Oocytes will be prepared for vitrification using the manual protocol
Automated Vitrification
Oocytes will be prepared for vitrification using the DaVitri device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Implantation failure
* Abnormal ovulation cycle
* Endometrial thickness \> 7mm
30 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Overture Life
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando Neuspiller, MD
Role: PRINCIPAL_INVESTIGATOR
WeFiv
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Halitus Instituto Médico
Buenos Aires, , Argentina
WeFIV Buenos Aires
Buenos Aires, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP-DV-000-GEN-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.